Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability

Figure 4

The concentration-time curve of rats after intravenous (iv, 1 mg/kg) and oral (po, 5 mg/kg) administration of gypenoside A (a) and gypenoside XLIX (b).

(a)

(b)